Who makes [14C]-AQX-1125 Oral Solution?

[14C]-AQX-1125 Oral Solution is developed by Aquinox Pharmaceuticals (Canada) Inc..

What development phase is [14C]-AQX-1125 Oral Solution in?

[14C]-AQX-1125 Oral Solution is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Aquinox Pharmaceuticals (Canada) Inc. · Phase 1 active Small molecule

Generic name	[14C]-AQX-1125 Oral Solution
Also known as	Radiolabelled AQX-1125 Oral Solution
Sponsor	Aquinox Pharmaceuticals (Canada) Inc.
Modality	Small molecule
Phase	Phase 1

No approved indications tracked.

No common side effects on file.